Outcomes of Patients Receiving Direct Oral Anticoagulants for Myeloproliferative Neoplasm-Associated Venous Thromboembolism in a Large Tertiary Centre in the UK

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.16485
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Development of Treatment of Cancer-Associated Venous Thromboembolism With Direct Oral Anticoagulants

The Japanese Journal of Phlebology
2020English

Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2019English

Hypoalbuminemia for the Prediction of Venous Thromboembolism and Treatment of Direct Oral Anticoagulants in Metastatic Gastric Cancer Patients

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2019English

Real World Experience at a Single Centre Using Low Dose Direct Oral Anticoagulants After Unprovoked Venous Thromboembolism

British Journal of Haematology
Hematology
2019English

Recent Advances in the Treatment of Venous Thromboembolism in the Era of the Direct Oral Anticoagulants

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2017English

The Treatment of Venous Thromboembolism With New Oral Anticoagulants

Italian Journal of Medicine
Medicine
2013English

Anticoagulants in Venous Thromboembolism.

BMJ
1989English

Direct Oral Anticoagulants in Antiphospholipid Syndrome With Venous Thromboembolism: Impact of the European Medicines Agency Guidance

Research and Practice in Thrombosis and Haemostasis
2019English

Characteristics and Outcomes in Patients With Atrial Fibrillation Receiving Direct Oral Anticoagulants in Off-Label Doses

BMC Cardiovascular Disorders
Cardiovascular MedicineCardiology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy